Schedule 13G ownership disclosure

Tenaya Therapeutics Inc

Security class unavailable · CUSIP: 87990A106

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,028,435
Percent of class
3.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-24-001465
Form type
SC 13G/A
Filer
PRICE T ROWE ASSOCIATES INC /MD/
CIK
CIK 80255
Filed
Nov 14, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub